Navigation Links
Shire to Present Additional Scientific Data on ADHD Treatment Portfolio at American Psychiatric Association Annual Meeting
Date:5/1/2008

nformation please contact:

Porter Novelli for Shire:

Lucia Lodato

Lucia.Lodato@porternovelli.com

212.601.8037

917.617.3058 (on site at the meeting)

Lauren Plate

Lauren.Plate@porternovelli.com

212.601.8188

SHIRE PLC

Shire's strategic goal is to become the leading specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician. Shire focuses its business on attention deficit and hyperactivity disorder (ADHD), human genetic therapies (HGT), gastrointestinal (GI) and renal diseases. The structure is sufficiently flexible to allow Shire to target new therapeutic areas to the extent opportunities arise through acquisitions. Shire's in-licensing, merger and acquisition efforts are focused on products in niche markets with strong intellectual property protection either in the US or Europe. Shire believes that a carefully selected portfolio of products with strategically aligned and relatively small-scale sales forces will deliver strong results. For further information on Shire, please visit the Company's website: http://www.shire.com.

"SAFE HARBOR" STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995

Statements included herein that are not historical facts are forward-looking statements. Such forward-looking statements involve a number of risks and uncertainties and are subject to change at any time. In the event such risks or uncertainties materialize, Shire's results could be materially affected. The risks and uncertainties include, but are not limited to, risks associated with: the inherent uncertainty of pharmaceutical research, product development including, but not limited to the successful development of JUVISTA(R) (Human TGF(beta)3) and veleglucerase alfa (GA-GCB); manufacturing and commerc
'/>"/>

SOURCE Shire plc
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Shire Enhances its Orphan Drug Pipeline With the Acquisition of a New Clinical Candidate for Metachromatic Leukodystrophy
2. Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients
3. Northfield Laboratories Inc. Presentation at FDA/NIH Workshop on Hemoglobin-Based Oxygen Carriers
4. Medarex Announces Presentations at Annual Meeting of the American Society of Clinical Oncology
5. Dr. Calvin Grant Presents Results from Xibrom(TM) Combination Therapy with Lucentis(R) at the 2008 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO)
6. Interim Results from Boceprevir Phase II Study in Genotype 1 Treatment-Naive Hepatitis C Patients Presented At EASL
7. Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL)
8. Pharmasset Presents Results of 4-Week Combination Study of R7128 for the Treatment of Chronic Hepatitis C
9. Idenix Pharmaceuticals Presents Positive Preclinical Data on HCV Programs at The Annual Meeting of The European Association for the Study of the Liver (EASL)
10. Romark Announces Presentation of New Data for Nitazoxanide in Chronic Hepatitis C at EASL 2008
11. BioVex Agrees SPA With the FDA for a Pivotal Study With OncoVEX(GM-CSF) in Metastatic Melanoma and Announces Presentation of Phase II Results at ASCO

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)..., SANDIEGO,Nov.24/PRNewswire-FirstCall/--AnadysPh...titwillpresentatthe21stAnnualPiperJaffrayHealthcar...:00a.m.PST).TheconferenceisbeingheldatTheNewYorkPa...utiveOfficerofAnadys,willprovideanoverviewofAnadys... ,, Thecorporatepresentationwillbesimultaneousl...
(Date:11/24/2009)..., POTOMAC,Md.,Nov.24/PRNewswire/--Inadditiontofam...saddedPhiladelphiajurorstoherThanksgivinggratitude....Iamsothankfultothem,"shesaidofMonday,sverdictstot...ls. ,, Wisneskiisamong12,000womennationwidewhoh...rmonetherapydrugsPremarinandPrempro.Wisneskiandthe...
(Date:11/24/2009)..., SANDIEGO,Nov.24/PRNewswire/--Accumetrics,Inc.,a...174;System,thefirstrapidandeasy-to-usediagnosticsy...tiplateletagents(e.g.Plavix®andaspirin),annou...etrics,andGregoryJ.Tibbitts,ChiefFinancialOfficero...he21stAnnualPiperJaffrayHealthCareConferencebeingh...
Breaking Medicine Technology:Anadys Pharmaceuticals to Present at the Piper Jaffray Healthcare Conference 2Maryland Woman Thankful for Wyeth Verdicts 2Accumetrics to Present at the 21st Annual Piper Jaffray Health Care Conference 2Warner Chilcott Announces Earnings Release Date and Conference Call For Second Quarter 2009 Financial Results 51693 1Michael J Fox Foundation Awards Over 242 Million for Validation of 10 Parkinsons Therapeutic Targets 4724 1Michael J Fox Foundation Awards Over 242 Million for Validation of 10 Parkinsons Therapeutic Targets 4724 2Michael J Fox Foundation Awards Over 242 Million for Validation of 10 Parkinsons Therapeutic Targets 4724 3Walking Biking to Work Pays Off 51688 1Walking Biking to Work Pays Off 51688 2
... DIEGO, April 13 Researchers from the,Barbara Ann...ted findings,showing that adding curcumin or resve...tive in preventing the growth of chemo-resistant c...ivered at the American Association,for Cancer Rese...ttp://www.newscom.com/cgi-bin/prnh/20071106/KARMAN...
... Gregory Ellison, Director of Advanced Medical Cen...r PROMETA(R), PHOENIX, April 11 With Arizona fac...Gregory Ellison, Director of Advanced Medical,Cent...treatment option that,shows high success rates and...) basis in 10 hours over five sessions. As the onl...
Other Medicine Technology:Karmanos Researchers Find Non-Toxic Agents Added to Conventional Chemotherapy Decrease Survival of Colon Cancer Cells 2Arizona Doctor Offers New Addiction Drug Treatment for Meth Addicts Showing More Than 60% Success Rate 2Arizona Doctor Offers New Addiction Drug Treatment for Meth Addicts Showing More Than 60% Success Rate 3
(Date:11/25/2009)...e/--Thanksgivingmealswillbedeliveredtoapproximatel...nkstoFaithInAction/VolunteerActionforAging,aprogra...HealthPlan.Formorethan17yearstheseorganizationshav...vingmealstoseniorsinneedinLongBeach,Lakewood,Signa.... ,, "Ourwarmholidaymealsaredeliveredtopeoplewh...
(Date:11/25/2009)...wswire/--TheBlackAIDSInstituterecentlyheldBoardofD...010. ,, ThenewBoardMembersareahighlydiversegrou...e,governmenthealthprograms,editorial,andbusinessen...rsonalbackgroundsincludingbothheterosexualandgayBl...esentingmultipleagegroups. ,, (Photo: http://ww...
(Date:11/25/2009)...ess,andPressJoinEfforttoEducate ,, MEMPHIS,Ten...ionalBipolarFoundationandtheMedicAlertFoundationre...ogram,whichisnowbeingwidelyacceptedasapreventivehe...lBipolarFoundationreceivedaproclamationofendorseme...fLouisianaMitchLandrieu.TheNationalBipolarFoundati...
(Date:11/25/2009)...atistically significant survival benefit from adju...tor (ER)-positive tumors had high levels of phosph...8-P), according to a brief communication published...l Cancer Institute . , Approximately 50% of brea...cal studies have shown that ER-alpha S118-P is req...
(Date:11/25/2009)...his simple question has been the focus of intense ...Modulates High Blood Pressure in Mice & Men, Does...tion has been the focus of intense research for ma... established a link between a novel gene, phosduci...ce as well as humans. The studies were directed by...
Breaking Medicine News(10 mins):Health News:SCAN Employees and Community Volunteers to Help Deliver One Thousand Thanksgiving Meals to Homebound Seniors 2Health News:Black AIDS Institute Announces 2010 Board Election Results 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 3Health News:New stress-related gene modulates high blood pressure in mice and men 2
...ge-old conception that memory capacity is solely d... the brain, a recent research demonstrates that //...increase their capacity to remember what is really...y, does not depend on extra storage space in the b...
...nese city in northeastern China, has suspended dri...ation, fearing possibility of contamination by che..., northeastern China, Tuesday "made a U-turn by ad...ther reports said the city had suspended its publi...
...tals Group is planning expansion of its super-spec...elhi, and bigger units in Kolkata and Bangalore.//...ew hospital at Pitampura (in west Delhi) which wou...he existing 110-bed cardiac care hospital in Banga...
...ines were issued today by the National Institute f...ational Collaborating Centre for Mental Health,// ... obsessive-compulsive disorder (OCD) and body dysm... is characterized by the occurrence of obsessions ...
...ai International Forum on a Healthy City has raise...g specific groups such as young people, specially ...s.// Smoking, which still remains one of the lead...unicipal Center for Disease Prevention and Control...
...ate over the safety of artificial sweeteners got a... Control Council today stated that a rat study con... contradictory with the extensive scientific resea... of aspartame. The study, to be published in Envir...
Other Medicine News:Health News:Wockhardt Group Plans Hospital In Delhi By End-2007 2Health News:Aspartame, Artificial Sweetener, A Safe Bet! 2Health News:Aspartame, Artificial Sweetener, A Safe Bet! 3
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
Medicine Products: